Dr. Wu Skincare Co., Ltd. (TPEX:6523)
Taiwan · Delayed Price · Currency is TWD 98.20
0.00 (0.00%)
May 29, 2026, 1:08 PM CST
Dr. Wu Skincare Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 280.33 | 350.27 | 476.25 | 424.73 | 339.98 | 296.24 |
Depreciation & Amortization | 10.53 | 9.65 | 8.42 | 9.42 | 9.77 | 12.16 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.14 |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.97 |
Loss (Gain) From Sale of Investments | -0.27 | -0.07 | -1.09 | -0.89 | 1.88 | 1.06 |
Provision & Write-off of Bad Debts | 0.04 | 0.02 | -0.05 | 0.05 | -0.07 | 0.07 |
Other Operating Activities | -43.5 | -28.39 | -25.09 | 17.23 | 7.06 | -82.31 |
Change in Accounts Receivable | 2.99 | 44.45 | -33.53 | -11.15 | 18.72 | -46.66 |
Change in Inventory | 6.6 | -6.75 | 26.97 | -73.56 | -0.02 | -12.17 |
Change in Accounts Payable | -14.73 | 3.9 | -36.8 | 15.98 | -43.24 | 61.43 |
Change in Unearned Revenue | 5.68 | 10.08 | 3.26 | 0.21 | -5.55 | 1.15 |
Change in Other Net Operating Assets | -16.54 | -42.25 | 18.84 | 10.42 | -2.7 | 62.09 |
Operating Cash Flow | 231.14 | 340.92 | 437.18 | 392.44 | 325.83 | 294.17 |
Operating Cash Flow Growth | -54.79% | -22.02% | 11.40% | 20.44% | 10.76% | -2.24% |
Capital Expenditures | -6.39 | -5.91 | -2.75 | -2.95 | -1.59 | -3.26 |
Divestitures | - | - | - | - | - | 250.83 |
Sale (Purchase) of Intangibles | - | - | - | -0.33 | - | -0.11 |
Investment in Securities | 169.94 | 141.96 | -86.47 | -105.54 | -330.5 | 557.02 |
Other Investing Activities | -7.64 | -7.64 | 0.02 | 0.17 | -0.63 | 3 |
Investing Cash Flow | 155.9 | 128.4 | -89.21 | -108.64 | -332.73 | 807.48 |
Long-Term Debt Repaid | - | -10.01 | -9.84 | -9.99 | -9.83 | -9.41 |
Net Debt Issued (Repaid) | -10.29 | -10.01 | -9.84 | -9.99 | -9.83 | -9.41 |
Common Dividends Paid | -450.48 | -450.48 | -495.52 | -450.48 | -360.38 | -775.72 |
Other Financing Activities | - | - | - | - | - | -0.23 |
Financing Cash Flow | -460.77 | -460.49 | -505.36 | -460.47 | -370.21 | -785.36 |
Net Cash Flow | -73.73 | 8.84 | -157.39 | -176.67 | -377.1 | 316.3 |
Free Cash Flow | 224.75 | 335.01 | 434.43 | 389.49 | 324.24 | 290.92 |
Free Cash Flow Growth | -55.76% | -22.88% | 11.54% | 20.13% | 11.45% | -2.74% |
Free Cash Flow Margin | 20.48% | 28.68% | 34.98% | 34.25% | 34.98% | 26.30% |
Free Cash Flow Per Share | 4.20 | 7.41 | 9.62 | 8.64 | 7.19 | 6.45 |
Cash Interest Paid | 1.31 | 1.37 | 0.82 | 0.26 | 0.52 | 0.76 |
Cash Income Tax Paid | 117.71 | 117.7 | 143.33 | 82.2 | 79.16 | 158.33 |
Levered Free Cash Flow | 158.3 | 248.96 | 405.5 | 167.7 | 203.32 | 526.44 |
Unlevered Free Cash Flow | 159.12 | 249.82 | 406.01 | 167.86 | 203.65 | 526.91 |
Change in Working Capital | -15.99 | 9.44 | -21.26 | -58.09 | -32.79 | 65.85 |